Fresenius Medical Care AG (FME.DE)
- Previous Close
37.79 - Open
37.85 - Bid 37.70 x 38700
- Ask 37.74 x 105300
- Day's Range
37.64 - 38.12 - 52 Week Range
30.16 - 49.62 - Volume
93,294 - Avg. Volume
433,463 - Market Cap (intraday)
11.07B - Beta (5Y Monthly) 0.93
- PE Ratio (TTM)
22.19 - EPS (TTM)
1.70 - Earnings Date May 7, 2024
- Forward Dividend & Yield 1.19 (3.15%)
- Ex-Dividend Date May 17, 2024
- 1y Target Est
39.00
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
www.freseniusmedicalcare.com119,845
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: FME.DE
Performance Overview: FME.DE
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FME.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FME.DE
Valuation Measures
Market Cap
11.09B
Enterprise Value
21.60B
Trailing P/E
22.23
Forward P/E
11.65
PEG Ratio (5yr expected)
0.43
Price/Sales (ttm)
0.57
Price/Book (mrq)
0.81
Enterprise Value/Revenue
1.11
Enterprise Value/EBITDA
6.73
Financial Highlights
Profitability and Income Statement
Profit Margin
2.57%
Return on Assets (ttm)
2.73%
Return on Equity (ttm)
4.84%
Revenue (ttm)
19.45B
Net Income Avi to Common (ttm)
499M
Diluted EPS (ttm)
1.70
Balance Sheet and Cash Flow
Total Cash (mrq)
1.56B
Total Debt/Equity (mrq)
81.28%
Levered Free Cash Flow (ttm)
1.33B
Research Analysis: FME.DE
Company Insights: FME.DE
FME.DE does not have Company Insights